Kenya
Kenya began administering the first doses of lenacapavir—a groundbreaking twice-yearly HIV prevention injection—in a Nairobi slum on Thursday, offering new hope in the country's fight against the virus.
"Today is a moment of hope for thousands of Kenyan families," Health Minister Aden Duale said during the launch in Kawangware.
The drug, which reduces HIV transmission risk by over 99.9%, will be provided free of charge.
Hope and relief
Samson Mutua, 27, became the first recipient. Peace Lawrence, a 23-year-old sex worker, called the injection "a relief," saying she often forgot daily PrEP pills.
"Having sex with multiple partners always leaves me in fear," she told AFP.
Community health worker Carol Njomo explained eligibility requires being HIV-negative, over 15, and at high risk.
Cushioning against aid cuts
Kenya received 21,000 doses through Gilead Sciences and the Global Fund.
The rollout comes as African countries grapple with U.S. aid cuts affecting HIV programs across the continent.
02:28
Zimbabwe roll-out of long-acting HIV prevention drug gets underway
01:01
Zimbabwe launches groundbreaking HIV prevention drug Lenacapavir
00:52
Workers at Kenya's main airport call off strike after two days of disruption
Go to video
Kenya airport strike leaves thousands of passengers stranded
02:23
Kenyan court dismisses compensation claim by victims of 1998 Nairobi bombing
01:40
Cuts in USAID funding cripples healthcare in Malawi